Patents Assigned to NeuTech Pharma PLC
  • Publication number: 20030065145
    Abstract: The present invention concerns immunogenic epitopes of Shigella-like toxins (SLTs), particularly the Shigella-like toxin of E. coli O157:H7, their use as immunogens and in treatment or diagnosis, agents (for example antibodies and antigen-binding fragments) which specifically neutralise them, their use in treatment and diagnosis, and methods for same.
    Type: Application
    Filed: May 30, 2002
    Publication date: April 3, 2003
    Applicant: NeuTech Pharma PLC
    Inventors: James Peter Burnie, Ruth Christine Matthews
  • Patent number: 6410024
    Abstract: The present invention concerns immunogenic epitopes of Shigella-like toxins (SLTs), particularly the Shigella-like toxin of E. coli 0157:H7, their use as immunogens and in treatment or diagnosis, agents (for example antibodies and antigen-binding fragments) which specifically neutralise them, their use in treatment and diagnosis, and methods for same.
    Type: Grant
    Filed: January 20, 2000
    Date of Patent: June 25, 2002
    Assignee: NeuTech Pharma PLC
    Inventors: James Peter Burnie, Ruth Christine Matthews